Human serum albumin (HSA) contributes to the stabilization of (À)-epigallocatechin gallate (EGCg) in serum. We characterize in the present study the mechanisms for preventing EGCg oxidation by HSA. EGCg was stable in human serum or buffers with HSA, but (À)-epigallocatechin (EGC) was unstable. We show by comparing EGCg and EGC in a neutral buffer that EGCg had a higher binding affinity than EGC. This indicates that the galloyl moiety participated in the interaction of EGCg with HSA and that this interaction was of critical importance in preventing EGCg oxidation. The binding affinity of EGCg for HSA and protein carbonyl formation in HSA were enhanced in an alkaline buffer. These results suggest the reversible covalent modification of EGCg via Schiff-base formation, and that the immobilization of EGCg to HSA, through the formation of a stable complex, prevented the polymerization and decomposition of EGCg in human serum.
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The disease-preventive effects of green tea and its main constituent polyphenols have been identified by epidemiological findings and established through in vivo and in vitro experimental and clinical studies over the past decade, as reviewed recently. 1) Their diverse biological activities have been attributed to a group of polyphenol compounds, namely catechins, that are present in green tea leaves. The major catechins in a green tea extract are (À)-epicatechin (EC), (À)-epigallocatechin (EGC), (À)-epicatechin gallate (ECg), and (À)-epigallocatechin gallate (EGCg). The number of hydroxyl groups on the B-ring and the presence or absence of a galloyl moiety are responsible for differences in the structure and function of these catechins. These catechins have been found to act as free radical scavengers and have been widely studied for their antioxidative activity in vitro and in vivo.
2) In contrast, a wealth of data suggest that most of the relevant mechanisms for disease prevention by catechins, such as in cancer, are not related to their antioxidative properties, but rather are due to their pro-oxidative action and the direct interaction of catechins with target molecules. 3) Catechins with a pyrogallol-type structure on the B-ring, such as EGC and EGCg, possess strong antioxidative activities. 4) However, these pyrogalloltype catechins are not stable under typical experimental conditions such as those in physiological buffer solutions and cell culture media. For example, in a high-pH solutions, pyrogallol-type catechins undergo autoxidation to form reactive oxygen species (ROS), including superoxide (O 2 À ) and hydrogen peroxide, resulting in polymerization and decomposition. 5, 6) Several other factors, including temperature, oxygen concentration, antioxidant concentration, metal ions, concentration of pyrogallol-type catechins, and other tea ingredients, also affect the stability of pyrogallol-type catechins. 7) Furthermore, in vitro studies have indicated that the pyrogallol-type catechins are unstable in several cell culture media. 8, 9) ROS can cause oxidative modification to sensitive proteins that can lead to changes in the protein function.
10) The oxidation of flavonoids with a catechol structural motif in their B-ring has led to the formation of a flavonoid quinone which rapidly reacted with sulfhydryls in reduced glutathione or protein cysteine residues to form cysteinyl adducts. 11, 12) More recently, we have found that EGCg formed covalent adducts with protein sulfhydryls through autoxidation. 13) Thus, the oxidation of these catechins and the resulting production of ROS is thought to be responsible for certain biological activities. Some evidence has indicated that EGCg was stable in the neutral or slightly alkaline pH environment of the body, as EGCg and its metabolites have been detected in biological fluids after green tea ingestion.
14,15) Sang et al. have reported that oxidative products of EGCg could not be detected by using the sensitive mass spectrometric method in plasma samples of mice after their treatment with 50 mg/kg of EGCg.
7) The oxygen partial pressure in the internal organs and body fluids was much lower under normal conditions than under cell culture conditions. 16) In addition, we have previously shown that EGCg was stable in human serum even at a slightly alkaline pH level and that the antioxidative property and binding capacity of human serum albumin (HSA) contributed to the stabilization of EGCg in serum. 17) EGCg is therefore thought to be stable under anaerobic conditions in vivo, although the mechanism for EGCg stabilization has not yet been characterized in detail.
We compare in the present study the stability of EGC and EGCg in human serum and in a neutral buffer solution with HSA under aerobic conditions, and characterize the molecular mechanisms responsible for preventing EGCg oxidation by HSA in human serum.
Materials and Methods
Chemicals and reagents. EC, EGC, ECg, and EGCg were kindly provided by the Tokyo Food Techno Co. (Shizuoka, Japan). HSA, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), and 3,3 0 -dithiodipropionic acid (DTDP) were purchased from SigmaAldrich (St. Louis, MO, USA). Horseradish peroxidase (HRP)-conjugated streptavidin (avidin) and enhanced chemiluminescence (ECL) western blotting detection reagents were obtained from GE Healthcare UK (Buckinghamshire, UK). Biotin-LC-hydrazide was purchased from Pierce (Rockford, IL, USA). All other reagents were obtained from Wako Pure Chemical Industries (Osaka, Japan).
Stability of pyrogallol-type catechins in human serum and buffer solutions with HSA. Fresh human serum was prepared from whole blood. After allowing the whole blood to clot for 60 min at 25 C in sterile, silicone-coated tubes, the clear supernatant (human serum; 85.0 mg/mL of protein) was withdrawn by a pipette. EGC or EGCg at a concentration of 100 mM was dissolved in the human serum, and the solution incubated at 37 C for 60 min. EGC or EGCg at a concentration of 100 mM was also incubated in a 100 mM sodium phosphate buffer (PB) at pH 7.4 or 8.0 without (control) or with 30.0 mg/mL of HSA at 37 C for 60 min. The amount of each catechin was determined by an HPLC analysis as previously described. 18) Briefly, the catechins were separated by a nanospace Gulliver system (Jasco, Tokyo, Japan) with a UV detector, using a Capcell Pak C18 UG120 column (Shiseido Co., Tokyo, Japan) with a mobile phase consisting of 20% methanol (EGC) or 25% methanol (EGCg) with water and 0.1% TFA. The flow rate was 1.0 mL/min, and the elution profiles were monitored by the absorbance at 285 nm.
Evaluation of the interaction of pyrogallol-type catechins with HSA by a quartz crystal microbalance (QCM). A 27-MHz QCM (Affinix Q4; Initium, Tokyo, Japan) was employed to analyze the interaction between each catechin (EGC or EGCg) and HSA. HSA was immobilized on a ceramic sensor chip by using an amine coupling reaction. 19 ) A 1.0 mM drop of DTDP in ethanol was applied to the sensor chip to immobilize the DTDP directly on the gold electrode surface by Au-thiol interaction. The sensor chip was then activated by adding a coupling solution containing 520 mM EDC and 870 mM NHS. After the sensor chip had been immersed in phosphate-buffered saline (PBS), HSA was added to the PBS solution, and the immobilization was followed by monitoring the frequency change resulting from the change in mass at the electrode surface. The immobilized HSA generated a signal of about 350 Hz, indicating binding of about 10 ng of HSA. EGC (50, 100, 300, and 500 mM) or EGCg (0.1, 1.0, 5.0, and 10 mM) at four different concentrations was then added to 100 mM PB (pH 6.0-8.0) at 25 C. AQUA ver 1.5 software (Initium) was then used to monitor the frequency change.
Fluorescence quenching measurements. An excitation wavelength of 280 nm was used, and the emission spectra were recorded from 300 to 360 nm at 25 C. Titration quenching experiments were carried out on HSA (5.0 mM) placed on a quartz cell and titrated by the successive addition of EGC or EGCg (final concentrations of 2.5, 5.0, and 10.0 mM) in 100 mM PB (pH 7.4). Each solution was mixed thoroughly and stored for 30 min before taking measurements.
Biotin-labeling of protein carbonyls in HSA. Biotin-labeling of catechin-treated HSA was performed as previously reported. 20, 21) Briefly, HSA (30.0 mg/mL) was incubated with EC, EGC, ECg or EGCg at a concentration of 100 mM in 100 mM PB (3.0-8.0) at 37 C for 60 min. After diluting to 0.1 mg/mL, each sample was treated with 5.0 mM biotin-LC-hydrazide at room temperature for 60 min in the dark. The biotin-labeled proteins were subjected to 10% SDS-PAGE/ western blotting with HRP-avidin, the bands being visualized by a lumino-image analyzer (Fujifilm Co., Tokyo, Japan).
Results
Effect of HSA on the stability of pyrogallol-type catechins in human serum and aqueous solutions It has been reported that the pyrogallol-type catechins, EGC and EGCg (Fig. 1A) , were easily oxidized in a neutral or alkaline solution. 5, 6) The oxidation of catechins with a pyrogallol structural motif in their B-ring leads to the formation of oxidized catechins having an O-quinone structure. These oxidized catechins undergo autoxidation to form hydrogen peroxide, resulting in polymerization and decomposition (Fig. 1B) . To evaluate the effect of HSA on the stability of the pyrogalloltype catechins, EGC and EGCg at a concentration of 100 mM were incubated in human serum at 37 C for 60 min. Although EGC was unstable in human serum, EGCg was stable for over 1 h (Fig. 2A) . In addition, EGC was unstable in 100 mM PB (pH 7.4 and 8.0) with or without 30.0 mg/mL of HSA, although EGCg was stable in both buffers with HSA (Fig. 2B) . These results show that HSA stabilized EGCg, but not EGC, in human serum and aqueous solutions. Binding affinity of pyrogallol-type catechins with HSA in aqueous solutions Several analytical approaches, including electrophoresis, spectrofluorometry, and chromatography, have indicated that catechins noncovalently bind to serum albumin. [22] [23] [24] HPLC with an HSA column recently enabled us to show that the hydroxyl groups on the galloyl group of each catechin influenced the binding affinity for immobilized HSA in an acidic solution with 20% acetonitrile. 25) We investigated in a QCM in the present study the interaction between pyrogallol-type catechins (EGC and EGCg) and HSA immobilized under physiological conditions. Figure 3A shows typical time-courses characteristics of the frequency change for the catechins bound to HSA under different catechin concentrations. The injection of each catechin as a guest molecule into the cell caused a frequency change, indicating the interaction between each catechin and HSA. EGC showed the same degree of frequency change as EGCg, which possesses a galloyl moiety, at ca. 50 times its concentration, suggesting that the galloyl moiety playd an important role in this interaction. To support this result, we compared the binding of EGCg with that of EGC by a fluorescence quenching analysis. HSA has a single tryptophan residue at position 214. In order to obtain detailed information about the environment of this residue, tryptophan emission spectra were obtained at an excitation wavelength of 280 nm. Figure 3B shows the fluorescence emission spectra for HSA in PB (pH 7.4) and following the addition of EGC or EGCg; catechins were non-fluorescent under the experimental conditions. The fluorescence intensity of HSA gradually decreased following the addition of EGCg, while it showed almost no change following the addition of EGC, indicating that only EGCg interacted with HSA. These results and previous findings indicate that the galloyl moiety was responsible for the interaction of catechins with HSA.
Catechins are easily oxidized to form an O-quinone on the B-ring in solutions at alkaline pH values. 5, 7) However, the galloyl moiety containing EGCg was stable for 1 h in PB with HSA at both pH 7.4 and 8.0 (Fig. 2B) . To evaluate the effect of pH on the binding of tea catechins with HSA, the interaction under different pH conditions was examined by HSA-coated QCM. Changes in the frequency at pH 3.0, 6.0, and 8.0 following the addition of EGCg are shown in Fig. 3C . A rapid decrease in frequency was observed at pH 8.0, while no decrease was observed for 30 min under the other pH conditions. The same result was obtained with the addition of EGC (Fig. 3C) . These results indicate that the binding affinity of catechins was higher under a slightly alkaline condition than under an acidic condition.
Formation of protein carbonyl in HSA by catechininduced oxidative deamination
Oxidative deamination forms a protein carbonyl in the target protein by various polyphenolic compounds, supposedly through the oxidation of polyphenols to the corresponding quinones. 26) To assess the formation of protein carbonyl in HSA, HSA (30.0 mg/mL) was incubated with 100 mM each of the four catechins (EC, ECg, EGC and EGCg) in 100 mM PB (pH 7.4) at 37 C for 60 min to generate a protein carbonyl labeled with biotin-LC-hydrazide. SDS-PAGE/western blotting using HRP-avidin showed the formation of the protein carbonyl in biotin-labeled HSA to be higher for the pyrogallol-type catechins (EGC and EGCg) than for the corresponding catechol-type catechins (EC and ECg) (Fig. 4A) . The protein carbonyl formation was also higher for those catechins having a galloyl moiety (ECg and EGCg) than for the corresponding catechins lacking a galloyl moiety (EC and EGC). These results show that the number of hydroxyl groups on the B-ring and the presence of a galloyl moiety affected the formation of the protein carbonyl.
To evaluate the effect of pH on the formation of the protein carbonyl in HSA by the pyrogallol-type catechins, HSA (30.0 mg/mL) was incubated with EGC or EGCg at a concentration of 100 mM in 100 mM PB (at pH 3.0, 6.0, or 8.0) at 37 C for 60 min to generate a protein carbonyl labeled with biotin-LC-hydrazide. A difference between EGC and EGCg for the formation of the protein carbonyl were observed at pH 6.0 (Fig. 4B) at pH 3.0 was detected in the presence for both EGC and EGCg. These observations suggest that the formation of a protein carbonyl in HSA required catechin oxidation and that the mechanism for the oxidative deamination of HSA by EGCg was different from that by EGC.
Discussion
Several lines of evidence have indicated that pyrogallol-type catechins had poor stability in neutral and alkaline solutions. 5, 6) We have previously reported that the binding capacity of HSA contributed to the stabilization of EGCg and that HSA prevented EGCg oxidation by its antioxidative activity. 17) Furthermore, the hydroxyl groups on the galloyl group and the number of hydroxyl groups on the B-ring of each catechin have influenced the binding affinity for HSA in an acidic solution with acetonitrile by HPLC with an HSA column. 25) However, the mechanism for EGCg stabilization has not previously been characterized. This study provides evidence that HSA directly prevented EGCg oxidation through a reversible interaction, and a mechanism is proposed to explain the prevention of EGCg oxidation by HSA. This assertion is based on the following observations: i) EGCg, but not EGC, was stable in serum and even in a slightly alkaline buffer containing HSA (Fig. 2) ; ii) the binding affinity of EGCg was higher than that of EGC under physiological conditions (Fig. 3) ; iii) the binding affinity of EGCg was higher under slightly alkaline conditions than under acidic conditions (Fig. 3C) [26] [27] [28] Moreover, polyphenols are oxidatively converted to their corresponding quinones and gain amine oxidase-like activity under physiological pH conditions and temperature. 26) Amine oxidase, a kind of copper-containing amine oxidase, catalyzes oxidative deamination of the "-amino groups of lysine residues to form -aminoadipic -semialdehyde (AAS) residues. 29) It has been reported that green tea catechins (EC, ECg, EGC, and EGCg) oxidatively deaminated only the lysine residues of human and bovine serum albumin to AAS via Schiffbase formation; the order of protein carbonyl formation was as follows: EGCg > EGC > ECg > EC. 21, 30) These findings provide a mechanism for oxidative deamination by polyphenols involving quinone-mediated oxidation. The formation of Schiff-base intermediates (iminoquinone and iminophenol) is important in this mechanism. Schiff-base intermediates, which are usually reversible under physiological conditions, initiate the conversion of an amine substrate to an aldehyde in the presence of metal ions, O 2 , and ROS. However, protein-bound catechins, which use a galloyl moiety for the interaction, may be protected from metal ions, O 2 , and ROS because the B-ring is covered with proteins. The stability of the intermediates enhances the binding of catechins with HSA by their additional covalent binding ability. On the other hand, oxidation of the B-ring may assist in the formation of Schiff-base intermediates, assuming that a galloyl moiety is present for the binding of tea catechins with HSA. Studies of serum albumin-tea catechin interactions have suggested that the binding of catechins with serum albumin was stabilized by hydrogen-bonding forces and electrostatic forces from their phenol groups. 22) In addition, we have previously reported that the log P values for tea catechins in an octanol/water system based on their chemical structure exhibited the hydrophobic property of the catechins. 18) A comparison of the log P values (EGCg > EGC; ECg > EC) also indicates that the galloyl moiety in the catechins increased the hydrophobic property, suggesting that the affinity of tea catechins for HSA was influenced by the hydrophobicity that was derived from the galloyl moiety. The formation of a stable complex may have repressed the polymerization and decomposition of EGCg by preventing further oxidation. Taking these results together, we propose a mechanism for EGCg stabilization by HSA (Fig. 5 ) that involves the antioxidative activity of HSA appearing to be related to the inhibition of polymerization and decomposition.
In conclusion, this study provides fundamental information on the stability of EGCg under in vivo and in vitro conditions, and enable us to propose a stabilizing mechanism for EGCg in human serum. The findings encourage further investigation into the biological activities of both tea catechins and HSA. The binding ability of HSA in blood is an important factor in the transport and release of various endogenous and exogenous compounds. 31) Our results suggest a novel biological function of HSA in human blood. However, some aspects of the proposed mechanism are not yet clear, as the EGCg binding site has not been completely characterized; this therefore limits the understanding of the relationship between the binding site and stability. Future studies are needed to clarify this relationship and to determine whether the same reaction occurs in the catechin-HSA complex in vivo.
